Search

Your search keyword '"LI Wen-Fei"' showing total 559 results
Start Over Author "LI Wen-Fei"
559 results on '"LI Wen-Fei"'

3. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Author

Liu, Xu, Zhang, Yuan, Yang, Kun-Yu, Zhang, Ning, Jin, Feng, Zou, Guo-Rong, Zhu, Xiao-Dong, Xie, Fang-Yun, Liang, Xiao-Yu, Li, Wen-Fei, He, Zhen-Yu, Chen, Nian-Yong, Hu, Wei-Han, Wu, Hai-Jun, Shi, Mei, Zhou, Guan-Qun, Mao, Yan-Ping, Guo, Rui, Sun, Rui, Huang, Jing, Liang, Shao-Qiang, Wu, Wei-Li, Su, Zhen, Li, Ling, Ai, Ping, He, Yu-Xiang, Zang, Jian, Chen, Lei, Lin, Li, Huang, Shao Hui, Xu, Cheng, Lv, Jia-Wei, Li, Ying-Qing, Hong, Shu-Bin, Jie, Yu-Sheng, Li, Hao, Huang, Sai-Wei, Liang, Ye-Lin, Wang, Ya-Qin, Peng, Ying-Lin, Zhu, Jin-Han, Zang, Sheng-Bing, Liu, Song-Ran, Lin, Qing-Guang, Li, Hao-Jiang, Tian, Li, Liu, Li-Zhi, Zhao, Hong-Yun, Lin, Ai-Hua, Li, Ji-Bin, Liu, Na, Tang, Ling-Long, Chen, Yu-Pei, Sun, Ying, and Ma, Jun

Published
2024
Full Text
View/download PDF

4. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

Author

Aupérin, Anne, Blanchard, Pierre, Benhamou, Ellen, Bourhis, Jean, Carmel, Alexandra, Chakrabandhu, Somvilai, Chan, Anthony TC, Chen, Lei, Chen, Ming-Yuan, Chen, Qiu-Yan, Chen, Yong, Chappell, Richard J, Choi, Horace, Chua, Daniel TT, Chua, Melvien Lee Kiang, Fountzilas, George, Higgins, Julian, Hong, Ming Huang, Hong, Ruey-Long, Huang, Pei-Yu, Hui, Edwin Pun, Hsiao, Chin-Fu, Kam, Michael, Koliou, Georgia Angeliki, Kwong, Dora L W, Lacas, Benjamin, Lai, Shu-Chuan, Lam, Ka On, LeBlanc, Michael L, Lee, Anne WM, Lee, Ho Fun Victor, Li, Wen Fei, Lim, Yoke, Ma, Brigette, Ma, Jun, Mai, Hai-Qiang, Mo, Frankie, Moon, James, Ng, Wai Tong, Ngan, Roger, Ollivier, Camille, O'Sullivan, Brian, Petit, Claire, Pignon, Jean-Pierre, Poh, Sharon X, Rücker, Gerta, Sham, Jonathan, Soong, Yoke Lim, Sun, Ying, Tan, Terence, Tang, Lin-Quan, Tung, Yuk, Wee, Joseph, Wu, Xuang, Xu, Tingting, Zhang, Li, Zhang, Yuan, Zhu, Guopei, Lee, Anne, Chan, Anthony T C, Li, Wen-Fei, Ngan, Roger K C, Hui, Edwin P, and Auperin, Anne

Published
2023
Full Text
View/download PDF

5. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

Author

Lv, Jiawei, Wei, Yuan, Yin, Jian-Hua, Chen, Yu-Pei, Zhou, Guan-Qun, Wei, Chen, Liang, Xiao-Yu, Zhang, Yuan, Zhang, Cui-Juan, He, Shi-Wei, He, Qing-Mei, Huang, Zhuo-Li, Guan, Jia-Li, Shen, Jia-Yi, Li, Xiao-Min, Li, Jun-Yan, Li, Wen-Fei, Tang, Ling-Long, Mao, Yan-Ping, Guo, Rui, Sun, Rui, Zheng, Yu-Hui, Zhou, Wen-Wen, Xiong, Ke-Xu, Wang, Si-Qi, Jin, Xin, Liu, Na, Li, Gui-Bo, Kuang, Dong-Ming, Sun, Ying, and Ma, Jun

Published
2023
Full Text
View/download PDF

7. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival

Author

Cui Rui-Xue, Liu Na, He Qing-Mei, Li Wen-Fei, Huang Bi-Jun, Sun Ying, Tang Ling-Long, Chen Mo, Jiang Ning, Chen Lei, Yun Jing-Ping, Zeng Jing, Guo Ying, Wang Hui-Yun, and Ma Jun

Subjects
BRMS1, Nasopharyngeal carcinoma, Metastasis, Prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Breast cancer metastasis suppressor 1 (BRMS1) is a metastasis suppressor gene. This study aimed to investigate the impact of BRMS1 on metastasis in nasopharyngeal carcinoma (NPC) and to evaluate the prognostic significance of BRMS1 in NPC patients. Methods BRMS1 expression was examined in NPC cell lines using quantitative reverse transcription-polymerase chain reaction and Western blotting. NPC cells stably expressing BRMS1 were used to perform wound healing and invasion assays in vitro and a murine xenograft assay in vivo. Immunohistochemical staining was performed in 274 paraffin-embedded NPC specimens divided into a training set (n = 120) and a testing set (n = 154). Results BRMS1 expression was down-regulated in NPC cell lines. Overexpression of BRMS1 significantly reversed the metastatic phenotype of NPC cells in vitro and in vivo. Importantly, low BRMS1 expression was associated with poor distant metastasis-free survival (DMFS, P P Conclusions Low expression of the metastasis suppressor BRMS1 may be an independent prognostic factor for poor prognosis in NPC patients.

Published
2012
Full Text
View/download PDF

8. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma

Author

Li Wen-Fei, Liu Na, Cui Rui-Xue, He Qing-Mei, Chen Mo, Jiang Ning, Sun Ying, Zeng Jing, Liu Li-Zhi, and Ma Jun

Subjects
Nasopharyngeal carcinoma, Biomarker, MTA1, Prognosis, Medicine
Abstract

Abstract Background Metastasis-associated protein 1 (MTA1) has been associated with poor prognosis in several malignant carcinomas. The purpose of this study was to investigate the expression and prognostic value of MTA1 in nasopharyngeal carcinoma (NPC). Methods MTA1 expression was assessed using immunohistochemistry in paraffin-embedded tumor specimens from 208 untreated NPC patients. Cox regression analysis was used to calculate the hazard ratio (HR), 95% confidence interval (CI) and identify independent prognostic factors, and recursive partitioning analysis was used to create a decision tree. Results Nuclear overexpression of MTA1 was observed in 48.6% (101/208) of the NPC tissues. Nuclear overexpression of MTA1 correlated positively with N classification (P = 0.02), clinical stage (P = 0.04), distant metastasis (P < 0.01) and death (P = 0.01). Additionally, nuclear overexpression of MTA1 correlated significantly with poorer distant metastasis-free survival (DMFS; P P < 0.01). MTA1 had prognostic significance in NPC patients with stage II disease, but not stage III or IV disease. Multivariate analysis demonstrated that nuclear overexpression of MTA1 was independently associated with poorer DMFS (HR, 2.05; 95% CI, 1.13–3.72; P = 0.02) and poorer OS (HR, 1.98; 95% CI, 1.09–3.59; P = 0.03). Using recursive partitioning analysis, the NPC patients could be classified with a low, intermediate or high risk of distant metastasis and death, on the basis of clinical stage, age and MTA1 expression. Conclusion The results of this study suggest that nuclear overexpression of MTA1 correlates significantly with poorer DMFS and poorer OS in NPC. MTA1 has potential as a novel prognostic biomarker in NPC.

Published
2012
Full Text
View/download PDF

9. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system

Author

Sun Ying, Tang Ling-Long, Chen Lei, Li Wen-Fei, Mao Yan-Ping, Liu Li-Zhi, Lin Ai-Hua, Li Li, and Ma Jun

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Intensity-modulated radiation therapy (IMRT) provides excellent locoregional control for nasopharyngeal carcinoma (NPC), and has gradually replaced two-dimensional conventional radiotherapy as the first-line radiotherapy technique. Furthermore, in the new seventh edition of the American Joint Committee on Cancer (AJCC) staging system, retropharyngeal lymph nodes were upgraded from N0 to N1 disease as a result of their negative impact on the distant metastasis-free survival (DMFS) rates of NPC. This retrospective study was conducted in order to review the treatment outcomes and patterns of failure in NPC patients with N0 disease after IMRT in order to effectively guide treatment in the future. Methods We retrospectively reviewed data from 506 biopsy-proven nonmetastatic NPC patients. There were 191 patients with negative cervical lymph node involvement. According to the seventh edition of the American Joint Committee on Cancer (AJCC) staging system, 110 patients (21.7%) were staged with N0 disease, and 81 patients (16.0%) were reclassified with N1 disease due to the presence of RLN metastasis. All patients received IMRT as the primary treatment. Results In patients with negative cervical lymph node involvement, distant metastasis-free survival (DMFS) was significantly higher in patients without retropharyngeal lymph node (RLN) metastasis than those with RLN metastasis (95.9% vs. 88.1% respectively, P = 0.04). For N0 disease, the 5-year overall survival (OS), local relapse-free survival (LRFS), nodal relapse-free survival (NRFS) and DMFS rates were 93.8%, 97.1%, 99.1% and 95.9%, respectively. For T1N0, T2N0, T3N0 and T4N0, OS was 97.8%, 100%, 93.8% and 76.9%, LRFS was 100%, 92.9%, 100% and 88.9% and DMFS was 96.6%, 90.9%, 100% and 93.3%, respectively. OS and LRFS were higher in T1-3 N0 patients than T4N0 patients (P < 0.01 and P = 0.01, respectively). Conclusions The seventh edition of the AJCC N-staging system improves prognostic accuracy by upgrading RLN metastasis to N1 disease. IMRT produces excellent survival rates in T1-3 N0 disease; however, T4N0 disease remains a challenge and additional improvements are required to achieve a favorable prognosis for these NPC patients.

Published
2012
Full Text
View/download PDF

10. Nivolumab combined with radical chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): An investigator-initiated, open-label, multicenter, single-arm, phase II clinical trial.

Author

Xu, Cheng, primary, Shen, Liangfang, additional, Yang, Kun-Yu, additional, Hu, Desheng, additional, Chen, Xiaozhong, additional, Lin, Shaojun, additional, Jin, Feng, additional, Zhou, Qin, additional, Peng, Gang, additional, Huang, Jing, additional, Wu, Yuan, additional, Tao, Changjuan, additional, Li, Ji-Bin, additional, Zhao, Hongyun, additional, Hong, Shu-Bin, additional, Huang, Hui-Ling, additional, Li, Wen-Fei, additional, Zhou, Guan-Qun, additional, Sun, Ying, additional, and Ma, Jun, additional

Published
2024
Full Text
View/download PDF

17. Radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy in patients with low-risk nasopharyngeal carcinoma: Updated results from a multicenter, open-label, non-inferiority, randomized phase III trial.

Author

Guo, Rui, Zhang, Yuan, Zhang, Ning, Deng, Bin, Cheng, Zhi-Bin, Huang, Jing, Zhang, Fan, Mao, Yan-Ping, Li, Wen-Fei, Zhou, Guan-Qun, Chen, Yu-Pei, Xu, Cheng, Lin, Li, Zhang, Wei-Wei, Jiang, Xu, Liu, Qing, Sun, Ying, Ma, Jun, and Chen, Lei

Published
2024
Full Text
View/download PDF

18. Nivolumab combined with chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): A multicenter, single-arm, phase II clinical trial.

Author

Xu, Cheng, Shen, Liangfang, Yang, Kun-Yu, Hu, Desheng, Chen, Xiaozhong, Lin, Shaojun, Jin, Feng, Zhou, Qin, Peng, Gang, Huang, Jing, Wu, Yuan, Tao, Changjuan, Li, Ji-Bin, Zhao, Hongyun, Hong, Shu-Bin, Huang, Hui-Ling, Li, Wen-Fei, Zhou, Guan-Qun, Sun, Ying, and Ma, Jun

Published
2024
Full Text
View/download PDF

19. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients

Author

Aupérin, Anne, Blanchard, Pierre, Benhamou, Ellen, Bourhis, Jean, Carmel, Alexandra, Chakrabandhu, Somvilai, TC Chan, Anthony, Chen, Lei, Chen, Ming-Yuan, Chen, Qiu-Yan, Chen, Yong, Chappell, Richard J, Choi, Horace, TT Chua, Daniel, Lee Kiang Chua, Melvin, Fountzilas, George, Higgins, Julian, Hong, Ming-Huang, Hong, Ruey-Long, Huang, Pei-Yu, Pun Hui, Edwin, Hsiao, C.F., Kam, Michael, Angeliki Koliou, Georgia, LW Kwong, Dora, Lacas, Benjamin, Lai, Shu-Chuan, On Lam, Ka, LeBlanc, Michael L, WM Lee, Anne, Fun Victor Lee, Ho, Fei Li, Wen, Ma, Brigette, Ma, Jun, Mai, Hai-Qiang, Mo, Frankie, Moon, James, Tong Ng, Wai, Ngan, Roger, Ollivier, Camille, O'Sullivan, Brian, Petit, Claire, Pierre Pignon, Jean, Poh, Sharon X., Rücker, Gerta, Sham, Jonathan, Lim Soong, Yoke, Sun, Ying, Tan, Terence, Tang, Lin-Quan, Tung, Yuk, Wee, Joseph, Wu, Xuang, Xu, Tingting, Zhang, Li, Zhang, Yuan, Zhu, Guopei, Lee, Anne W.M., Wai Tong, Ng, Chan, Anthony T.C., Hong, Ruey Long, Li, Wen-Fei, Kwong, Dora L.W., Poh, Sharon S.X., and Pignon, Jean-Pierre

Published
2022
Full Text
View/download PDF

21. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Author

Chen, Yu-Pei, Liu, Xu, Zhou, Qin, Yang, Kun-Yu, Jin, Feng, Zhu, Xiao-Dong, Shi, Mei, Hu, Guo-Qing, Hu, Wei-Han, Sun, Yan, Wu, Hong-Fen, Wu, Hui, Lin, Qin, Wang, Hui, Tian, Ye, Zhang, Ning, Wang, Xi-Cheng, Shen, Liang-Fang, Liu, Zheng-Zheng, Huang, Jing, Luo, Xiu-Ling, Li, Ling, Zang, Jian, Mei, Qi, Zheng, Bao-Min, Yue, Dan, Xu, Jing, Wu, San-Gang, Shi, Yan-Xia, Mao, Yan-Ping, Chen, Lei, Li, Wen-Fei, Zhou, Guan-Qun, Sun, Rui, Guo, Rui, Zhang, Yuan, Xu, Cheng, Lv, Jia-Wei, Guo, Ying, Feng, Hui-Xia, Tang, Ling-Long, Xie, Fang-Yun, Sun, Ying, and Ma, Jun

Published
2021
Full Text
View/download PDF

23. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma

Author

Du, Xiao-Jing, primary, Wang, Gao-Yuan, additional, Zhu, Xiao-Dong, additional, Han, Ya-Qian, additional, Lei, Feng, additional, Shen, Liang-Fang, additional, Yang, Kun-Yu, additional, Chen, Lei, additional, Mao, Yan-Ping, additional, Tang, Ling-Long, additional, Li, Ling, additional, Wu, Zheng, additional, Xu, Gui-Qiong, additional, Zhou, Qin, additional, Huang, Jing, additional, Guo, Rui, additional, Zhang, Yuan, additional, Liu, Xu, additional, Zhou, Guan-Qun, additional, Li, Wen-Fei, additional, Xu, Cheng, additional, Lin, Li, additional, Chen, Yu-Pei, additional, Chen, Fo-Ping, additional, Liang, Xiao-Yu, additional, Chen, Si-Yuan, additional, Li, Shu-Qi, additional, Cui, Chun-Yan, additional, Li, Ji-Bin, additional, Ren, Jian, additional, Chen, Ming-Yuan, additional, Liu, Li-Zhi, additional, Sun, Ying, additional, and Ma, Jun, additional

Published
2024
Full Text
View/download PDF

25. Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patients

Author

Lou, Qiu-Yue, Li, Zhen, Teng, Ying, Xie, Qiao-Mei, Zhang, Man, Huang, Shun-Wei, Li, Wen-Fei, Chen, Yang-Fan, Pan, Fa-Ming, Xu, Sheng-Qian, Cai, Jing, Liu, Shuang, Tao, Jin-Hui, Liu, Sheng-Xiu, Huang, Hai-Liang, Wang, Fang, Pan, Hai-Feng, Su, Hong, Xu, Zhi-Wei, Hu, Wen-Biao, and Zou, Yan-Feng

Published
2021
Full Text
View/download PDF

26. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Author

Chen, Yu-Pei, Yin, Jian-Hua, Li, Wen-Fei, Li, Han-Jie, Chen, Dong-Ping, Zhang, Cui-Juan, Lv, Jia-Wei, Wang, Ya-Qin, Li, Xiao-Min, Li, Jun-Yan, Zhang, Pan-Pan, Li, Ying-Qin, He, Qing-Mei, Yang, Xiao-Jing, Lei, Yuan, Tang, Ling-Long, Zhou, Guan-Qun, Mao, Yan-Ping, Wei, Chen, Xiong, Ke-Xu, Zhang, Hong-Bo, Zhu, Shi-Da, Hou, Yong, Sun, Ying, Dean, Michael, Amit, Ido, Wu, Kui, Kuang, Dong-Ming, Li, Gui-Bo, Liu, Na, and Ma, Jun

Published
2020
Full Text
View/download PDF

27. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

Author

Chen, Yu-Pei, Lv, Jia-Wei, Mao, Yan-Ping, Li, Xiao-Min, Li, Jun-Yan, Wang, Ya-Qin, Xu, Cheng, Li, Ying-Qin, He, Qing-Mei, Yang, Xiao-Jing, Lei, Yuan, Shen, Jia-Yi, Tang, Ling-Long, Chen, Lei, Zhou, Guan-Qun, Li, Wen-Fei, Du, Xiao-Jing, Guo, Rui, Liu, Xu, Zhang, Yuan, Zeng, Jing, Yun, Jing-Ping, Sun, Ying, Liu, Na, and Ma, Jun

Published
2021
Full Text
View/download PDF

33. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

Author

Petit, Claire, primary, Lee, Anne, additional, Ma, Jun, additional, Lacas, Benjamin, additional, Ng, Wai Tong, additional, Chan, Anthony T C, additional, Hong, Ruey-Long, additional, Chen, Ming-Yuan, additional, Chen, Lei, additional, Li, Wen-Fei, additional, Huang, Pei-Yu, additional, Tan, Terence, additional, Ngan, Roger K C, additional, Zhu, Guopei, additional, Mai, Hai-Qiang, additional, Hui, Edwin P, additional, Fountzilas, George, additional, Zhang, Li, additional, Carmel, Alexandra, additional, Kwong, Dora L W, additional, Moon, James, additional, Bourhis, Jean, additional, Auperin, Anne, additional, Pignon, Jean-Pierre, additional, Blanchard, Pierre, additional, Aupérin, Anne, additional, Benhamou, Ellen, additional, Chakrabandhu, Somvilai, additional, Chan, Anthony TC, additional, Chen, Qiu-Yan, additional, Chen, Yong, additional, Chappell, Richard J, additional, Choi, Horace, additional, Chua, Daniel TT, additional, Chua, Melvien Lee Kiang, additional, Higgins, Julian, additional, Hong, Ming Huang, additional, Hui, Edwin Pun, additional, Hsiao, Chin-Fu, additional, Kam, Michael, additional, Koliou, Georgia Angeliki, additional, Lai, Shu-Chuan, additional, Lam, Ka On, additional, LeBlanc, Michael L, additional, Lee, Anne WM, additional, Lee, Ho Fun Victor, additional, Li, Wen Fei, additional, Lim, Yoke, additional, Ma, Brigette, additional, Mo, Frankie, additional, Ngan, Roger, additional, Ollivier, Camille, additional, O'Sullivan, Brian, additional, Petit, Claire, additional, Poh, Sharon X, additional, Rücker, Gerta, additional, Sham, Jonathan, additional, Soong, Yoke Lim, additional, Sun, Ying, additional, Tang, Lin-Quan, additional, Tung, Yuk, additional, Wee, Joseph, additional, Wu, Xuang, additional, Xu, Tingting, additional, and Zhang, Yuan, additional

Published
2023
Full Text
View/download PDF

40. Finite range effects of nuclear force in intermediate energy heavy ion collisions

Author

Chen, Lie-Wen, Zhang, Feng-Shou, and Li, Wen-Fei

Subjects
Nuclear Theory
Abstract

Within the framework of an isospin-dependent quantum molecular dynamics model, the zero-range 2-body part of the Skyrme interaction is replaced by a finite-range Gaussian 2-body interaction. From the transverse momentum analysis in the reaction of system $^{93}$Nb + $^{93}$Nb at energy of 400 MeV/nucleon and impact parameter $b$=3 fm, it is shown that the finite-range nuclear force enhances the transverse momentum of the reaction system and it can partly replace the momentum dependent part of the nucleon-nucleon interaction., Comment: 7 Pgaes in REVTex, 4 Figures, 1 Table

Published
2000

45. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Author

Sun, Ying, Li, Wen-Fei, Chen, Nian-Yong, Zhang, Ning, Hu, Guo-Qing, Xie, Fang-Yun, Sun, Yan, Chen, Xiao-Zhong, Li, Jin-Gao, Zhu, Xiao-Dong, Hu, Chao-Su, Xu, Xiang-Ying, Chen, Yuan-Yuan, Hu, Wei-Han, Guo, Ling, Mo, Hao-Yuan, Chen, Lei, Mao, Yan-Ping, Sun, Rui, Ai, Ping, Liang, Shao-Bo, Long, Guo-Xian, Zheng, Bao-Min, Feng, Xing-Lai, Gong, Xiao-Chang, Li, Ling, Shen, Chun-Ying, Xu, Jian-Yu, Guo, Ying, Chen, Yu-Ming, Zhang, Fan, Lin, Li, Tang, Ling-Long, Liu, Meng-Zhong, and Ma, Jun

Published
2016
Full Text
View/download PDF

47. Supplementary Materials from Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Author

Chen, Yu-Pei, primary, Tang, Ling-Long, primary, Yang, Qi, primary, Poh, Sharon-Shuxian, primary, Hui, Edwin P., primary, Chan, Anthony T.C., primary, Ong, Whee-Sze, primary, Tan, Terence, primary, Wee, Joseph, primary, Li, Wen-Fei, primary, Chen, Lei, primary, Ma, Brigette B.Y., primary, Tong, Macy, primary, Tan, Sze-Huey, primary, Cheah, Shie-Lee, primary, Fong, Kam-Weng, primary, Sommat, Kiattisa, primary, Soong, Yoke Lim, primary, Guo, Ying, primary, Lin, Ai-Hua, primary, Sun, Ying, primary, Hong, Ming-Huang, primary, Cao, Su-Mei, primary, Chen, Ming-Yuan, primary, and Ma, Jun, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Method from Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma

Author

Peng, Hao, primary, Dong, Di, primary, Fang, Meng-Jie, primary, Li, Lu, primary, Tang, Ling-Long, primary, Chen, Lei, primary, Li, Wen-Fei, primary, Mao, Yan-Ping, primary, Fan, Wei, primary, Liu, Li-Zhi, primary, Tian, Li, primary, Lin, Ai-Hua, primary, Sun, Ying, primary, Tian, Jie, primary, and Ma, Jun, primary

Published
2023
Full Text
View/download PDF

49. Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial

Author

Mao, Yan-Ping, primary, Wang, Shun-Xin, additional, Gao, Tian-Sheng, additional, Zhang, Ning, additional, Liang, Xiao-Yu, additional, Xie, Fang-Yun, additional, Zhang, Yuan, additional, Zhou, Guan-Qun, additional, Guo, Rui, additional, Luo, Wei-Jie, additional, Li, Yong-Jie, additional, Liang, Shao-Qiang, additional, Lin, Li, additional, Li, Wen-Fei, additional, Liu, Xu, additional, Xu, Cheng, additional, Chen, Yu-Pei, additional, Lv, Jia-Wei, additional, Huang, Shao-Hui, additional, Liu, Li-Zhi, additional, Li, Ji-Bin, additional, Tang, Ling-Long, additional, Chen, Lei, additional, Sun, Ying, additional, and Ma, Jun, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results